Novo Nordisk reports falling market share and margins; 2026 outlook projects a 5-13% decline in sales and operating profit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results